Aurobindo Pharma (AUROPHARMA.NS) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
0375M750M1B2B2B2B3B3BQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Operating Expenses

Research And Development ExpensesSelling General And Administrative Expenses
050M100M150M200M250M300M350M400MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

EBITDA

EBITDA
038M75M112M150M188M225M262M300MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

EPS

EPSEPS Diluted
000001111Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Revenue Variation (%)

Revenue Variation
-8-6-4-3-11246Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
0255075100125150175200Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Revenue YoY Variation (%)

Revenue YoY Variation
02581012151820Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
0255075100125150175200Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Price-to-Earning Ratio

P/E Ratio
048111519222630Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Income Breakdown

Operating IncomeTotal Other Income Expenses NetNet Income
075M150M225M300M375M450M525M600MQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Per Share Metrics

Revenue Per ShareNet Income Per Share
001122233Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026

Expense Ratios

Research And Ddevelopement To Revenue
000001111Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
💰 Cash Flow Statement

Operating Cash Flow

Free Cash Flow

Cash Flow to Debt Ratio

🏦 Balance Sheet
📈 Key Metrics